Intravitreal injection of anti-VEGF was required to reduce the hyphema or vitreous hemorrhage in eyes with NVG or to treat the macular edema due to diabetic retinopathy or retinal vein occlusion. Here, VEGFA is linked to retinal vein occlusion.